SCYNEXIS INC Form 8-K Summary
Business Context and Reporting Period
SCYNEXIS, Inc. (SCYX) filed this Current Report on Form 8-K on December 17, 2020, to disclose an equity underwriting agreement entered into on the same date. The Company is a Delaware corporation with principal executive offices in Jersey City, New Jersey.
Key Financial Metrics and Offering Details
The filing details a public offering expected to generate approximately $79.5 million in net proceeds after deducting underwriting discounts and estimated offering expenses. The offering structure includes:
- Common Stock: 8,340,000 shares at a public price of $6.25 per share.
- Pre-funded Warrants: 5,260,000 warrants exercisable for common stock at $0.001 per share, sold at a public price of $6.249 per warrant.
- Warrants: Two series of warrants accompanying the stock and pre-funded warrants to purchase an aggregate of 13,600,000 shares.
- Series 1 Warrants: 6,800,000 shares, one-year term, exercise price of $7.33.
- Series 2 Warrants: 6,800,000 shares, three-and-a-half-year term, exercise price of $8.25.
The underwriters agreed to purchase the securities at $5.875 per share of common stock and $5.87406 per pre-funded warrant. The filing does not provide current revenue, profit, cash flow, or debt metrics as this is a transactional report rather than a periodic financial statement.
Material Changes and Unusual Items
The primary material change is the execution of the Equity Underwriting Agreement, which will significantly increase the Company's cash liquidity upon closing. In connection with this offering, the Company terminated its Controlled Equity Offering SM Sales Agreements with Cantor Fitzgerald & Co. and Ladenburg Thalmann & Co. Inc.
Guidance, Outlook, and Risks
The offering is expected to close on or about December 21, 2020, subject to customary closing conditions. The Company notes that forward-looking statements regarding the completion, timing, and size of the offering involve risks and uncertainties. There is no assurance that the offering will be completed on the anticipated terms or at all. The filing states there is not expected to be any trading market for the pre-funded warrants or the specific series of warrants issued in this offering.
Investor Verification Checklist
- Verify the closing of the offering on or about December 21, 2020.
- Confirm the final net proceeds received by the Company after all expenses.
- Review the impact of the new share issuance on existing shareholder dilution.
- Monitor the exercise activity of the Series 1 and Series 2 warrants.
- Check subsequent filings for the updated capitalization table and cash position.